Conversely, induction of the T cell-driven IL-10 response is well-known to mitigate diseases in mice ranging from asthma [26,27] and inflammatory bowel disease [28] to multiple sclerosis [29,30]. This evidence concerns the gene IL10 and inflammatory bowel disease.